Humanized Rag2-/-γc-/- (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year

被引:51
|
作者
Berges, Bradford K. [1 ]
Akkina, Sarah R. [1 ]
Remling, Leila [1 ]
Akkina, Ramesh [1 ]
机构
[1] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA
关键词
HIV/AIDS pathogenesis; Chronic HIV infection in humanized mice; HIV animal models; Hematopoietic stem cells; SCID-hu mice; Rag2-/- gamma c-/- mice; RAG-hu mice; HUMAN IMMUNE-SYSTEM; T-CELL DEPLETION; VIRUS-INFECTION; MOUSE; TRANSMISSION; RESPONSES; MODEL; INHIBITORS; THERAPY;
D O I
10.1016/j.virol.2009.10.034
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 infection is characterized by life-long viral persistence and continued decline of helper CD4 T cells. The new generation of humanized mouse models that encompass RAG-hu, hNOG and BLT mice have been shown to be susceptible to HIV-1 infection and display CD4 T cell loss. Productive infection has been demonstrated with both R5 and X4 tropic strains of HIV-1 via direct injection as well as mucosal exposure. However the duration of infection in these mice was evaluated for a limited time lasting only weeks post infection, and it is not established how long the viremia can be sustained, and if the CD4 T cell loss persists throughout the life of the infected humanized mice. in the present study we followed the HIV-1 infected RAG-hu mice to determine the long-term viral persistence and CD4 T cell levels. Our results showed that viremia persists lifelong lasting for more than a year, and that CD4 T cell levels display a continuous declining trend as seen in the human. These studies provide a chronic HIV-1 infection humanized mouse model that can be used to dissect viral latency, long-term drug evaluation and immune-based therapies. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:100 / 103
页数:4
相关论文
共 23 条
  • [21] Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2-/-γc-/- Mouse
    Choudhary, Shailesh K.
    Rezk, Naser L.
    Ince, William L.
    Cheema, Manzoor
    Zhang, Liguo
    Su, Lishan
    Swanstrom, Ronald
    Kashuba, Angela D. M.
    Margolis, David M.
    JOURNAL OF VIROLOGY, 2009, 83 (16) : 8254 - 8258
  • [22] Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 years
    Vidal, F
    Peraire, J
    Domingo, P
    Broch, M
    Cairó, M
    Pedrol, E
    Montero, M
    Viladés, C
    Gutiérrez, C
    Sambeat, MA
    Fontanet, A
    Dalmau, D
    Deig, E
    Knobel, H
    Sirvent, JJ
    Richart, C
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (01) : 17 - 22
  • [23] Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection
    Rodés, B
    Toro, C
    Paxinos, E
    Poveda, E
    Martinez-Padial, M
    Benito, JM
    Jimenez, V
    Wrin, T
    Bassani, S
    Soriano, V
    AIDS, 2004, 18 (08) : 1109 - 1116